Catalytic (blue), Regulatory (pink), and Association domains (gray) are mapped onto the linear structure, and mutations used in this study are indicated, specifically the catalytic site K42R mutation that blocks kinase activity, the I205K T-site mutation that perturbs protein-protein interactions, the T286A mutation that prevents T286 autophosphorylation, the TT305/6DD mutations that block the binding of calmodulin, and the ∆344 deletion mutant that prevents holoenzyme oligomerization. For FPFA experiments the yellow fluorescent protein Venus was attached to the CaMKIIα catalytic domain by concatenating the Venus C-terminus to the CaMKIIα Nterminus using a flexible 15 amino-acid linker (dashed double arrow). Venus tag, was incubated with TAMRA-Autocamtide (100 nM) as described in the methods with the indicated concentrations of calcium-calmodulin (CaM). Note that because TAMRA concentrations were always at least 300 times greater than Venus concentrations, and because filters used in this assay were designed to isolate TAMRA excitation and emission, it is unlikely that Venus fluorescence significantly altered these measurements. Each data point represents the mean±SD from five different homogenates each measured in duplicate, and the resulting dose response curve was fit to the Hill equation. The 95% confidence interval for the EC50 for CaM binding to CaMKIIα was 2.8-4.9 nM while for V-CaMKIIα it was 2.2-3.7 nM. Similarly the 95% confidence interval for the Hill coefficient for CaMKIIα was 0.8-1.9 while for V-CaMKIIα it was 0.8-1.6. As these confidence intervals overlapped, we conclude that tagging CaMKIIα with Venus on its N-terminus does not alter the enzymes affinity for Calmodulin or its cooperativity for binding CaM. The divergence of the two dose response curves below 1 nM CaM suggest that while tagging CaMKIIα with Venus does not alter the kinases maximal activity, it might reduce the enzymes activity prior to activation.
